Barrios, C., Liu, M., Lee, S., Vanlemmens, L., Ferrero, J., Tabei, T., . . . SINGAPORE, C. S. I. O. (2014). Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer.
Chicago Style CitationBarrios, C.H., et al. Phase III Randomized Trial of Sunitinib Versus Capecitabine in Patients With Previously Treated HER2-negative Advanced Breast Cancer. 2014.
MLA引文Barrios, C.H., et al. Phase III Randomized Trial of Sunitinib Versus Capecitabine in Patients With Previously Treated HER2-negative Advanced Breast Cancer. 2014.
警告：這些引文格式不一定是100％准確.